Dr. Anthony Fauci's Conflicts of Interest & the Federal Government's Ties to Private Accreditation Bodies QA Expert Daryl Guberman ExposesFederal Agencies, Corporations, and Private Accreditation Bodies: How Fauci, NIH, CDC, Pfizer, Johnson & Johnson, and Government Officials Are Entangled in Ethical and Legal Violations.
By: GUBERMAN-PMC,LLC Dr. Fauci's Royalties and Federal Law Violations Fauci's Royalties And The $350 Million Royalty Payment Stream HIDDEN By NIH https://perma.cc/ Gov't scientists got $325M in royalties from China, Russia, pharma firms: report https://nypost.com/ As Director of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Fauci received undisclosed royalty payments, raising questions about violations of federal laws, including:
Federal Employees Profiting from ANSI-ANAB Further scrutiny has revealed that federal officials beyond Fauci are personally profiting from their affiliations with ANSI-ANAB. Philip Mattson-DHS Executive Director Office of Standards who represented DHS on the ANSI-ANAB board. Philip Mattson received $262,814 in conjunction with his Federal Salary. Gordon Gillerman Executive Director of Standards who represented NIST on the ANSI-ANAB board receiving $120,000 plus his federal salary. Both Mattson and Gillerman represent their respective federal agencies while serving on the board of a private, non-profit entity. This arrangement is a direct violation of 18 U.S.C. § 209, which prohibits federal employees from receiving outside compensation related to their official duties. Their dual roles create a glaring conflict of interest, as these individuals influence regulatory decisions while financially benefiting from the very organizations they are meant to oversee. These violations further illustrate how deeply embedded ANSI-ANAB are within the federal regulatory system, raising serious concerns about the integrity of U.S. safety and accreditation standards. ANSI, ANAB, and the Global Accreditation Network ANSI-ANAB have played a central role in forming international accreditation bodies such as the International Accreditation Forum (IAF incorporated in Delaware/ It is an association of national and international accreditation bodies, equivalent in accreditation to ANSI-ANAB) along with IAF sister organization the International Laboratory Accreditation Cooperation (ILAC Australia), which regulate industries ranging from pharmaceuticals, aerospace, automotive, defense and other industries. ANSI-ANAB serve as underwriters for global accreditation, assuming legal responsibility for systematic and product failures. However, recent moves to create a new entity, the Global Accreditation Cooperation (GLOBAC), suggest an attempt to shift liability further down the regulatory chain, shielding ANSI-ANAB from accountability. Fauci, Wuhan, and the Gain-of-Function Controversy In 2017, Xiao Jianhua, a Chinese national and executive of China's National Accreditation Service, was appointed to lead the IAF after being handed control by ANSI/ANAB's former Vice President and IAF Chairman and Principal on the 990-tax form (2009-2015). Randy Dougherty. That same year, Xiao Jianhua was documented certifying a bio-level four laboratory in Wuhan, China—despite concerns raised by scientists about a lack of trained technicians to handle high-contagion materials. This aligns with statements made under deposition by Pamela Sale, ANSI/ANAB's Vice President of Laboratory Accreditation, who admitted that there were no uniform safety protocols across accredited laboratories. In 2018, Randy Dougherty retired from his leadership roles at ANSI-ANAB, and the IAF. However, the damage done during his tenure continues to resonate. Particularly troubling is his decision in 2015 to hand over the IAF leadership to Xiao Jianhua, who served as Chairman from 2015–2021 and Chief Executive of the China National Accreditation Service (CNAS) Beijing China. This move raised serious national security concerns. Xiao Jianhua, a high-ranking official in the Chinese government, was directly responsible for certifying high-risk facilities like the Wuhan Institute of Virology (WIV), which was the subject of controversy due to its bio-safety level 4 certification despite major deficiencies in staff training and laboratory procedures. Xiao Jianhua, also must adhere to the Chinese National Intelligence Law article 7 which mandates all Chinese nationals to take data from organizations and send it back to China. This is called hacking or cybersecurity infiltration. Additionally, in 2019, the CDC—an ANSI/ANAB member—issued a document titled "Volume 25: Virology Lab Training," which identified Wuhan as the sole facility mentioned in the training materials. The document emphasized that "the first line of containment in any bio-level four laboratory is highly trained technicians," ALL INFORMATION Contained in link further documents all information in press release: 1. Pfizer, J&J, Quality issues 2. 2017-2018 US scientists report about lack of trained technicians in Wuhan China. 3. Volume 25 May 2019 CDC training document 4. Pamela Sale VP Laboratory accreditation for ANSI-ANAB Texas deposition All contained in this link: https://www.prlog.org/ Pfizer's CEO and Israel's Vaccine Strategy Albert Bourla, CEO of Pfizer, has been a prominent advocate for COVID-19 vaccinations. In an interview, he emphasized the importance of vaccination efforts. However, it is noteworthy that during this period, he had not yet received the vaccine himself, raising questions about vaccine distribution priorities and public messaging. In a separate development, Israeli Prime Minister Benjamin Netanyahu referred to Israel as a "laboratory" for Pfizer's COVID-19 vaccine due to the country's rapid vaccination campaign and data-sharing agreement with the company. This characterization has led to discussions about the ethical implications of such agreements and the transparency of vaccine trial data. See here Albert Bourla Pfizer CEO & Benjamin Netanyahu Isreal Prime Minister: https://www.prlog.org/ Congressional Integrity at Risk: How Big Pharma's Influence Shields Fauci and Undermines Public Trust How can we trust our public officials in Congress when many receive significant donations from major pharmaceutical companies—companies that also hold seats on the American National Standards Institute (ANSI) and the American National Accreditation Board (ANAB)? This raises a serious question: Is this financial entanglement the reason Anthony Fauci was never prosecuted? Fauci's own organization, the National Institutes of Health (NIH), is a member of ANSI- ANAB alongside the CDC, FDA, Pfizer, and Johnson & Johnson. This web of financial and regulatory influence suggests a troubling conflict of interest, where those responsible for oversight and accountability are deeply intertwined with the industries they are meant to regulate. If Congress is financially beholden to these corporations, true accountability remains out of reach, leaving the public to question whether their leaders are truly serving them—or the interests of Big Pharma. Guberman, who recently made waves by providing a deposition during a whistleblower hearing on Capitol Hill, Speaking at an April 17, 2024 Senate subcommittee meeting QA EXPERT DARYL GUBERMAN STANDS UP AT DHS SUBCOMMITTEE April 17,2024 Washington DC https://youtube.com/ Challenges for Robert F. Kennedy Jr. as Head of HHS: Conflict of Interest and Systemic Impotency https://www.prlog.org/ Biden Failed to Release COVID Origins Intelligence As Required By Law Nearly Two Years Ago; Trump Starts Process In First Week: https://www.prlog.org/ QA Expert: Daryl Guberman Exposes Global Accreditation Loopholes: How ANSI, ANAB, IAF, ILAC, & APAC May Enable Sanction Evasion and Shield Liability https://www.prlog.org/ Media Contact DARYL GUBERMAN 203 556 1493 ***@yahoo.com Photos: https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ https://www.prlog.org/ End
Page Updated Last on: Jan 31, 2025
|
Account Phone Number